Executive record

Jennifer Fulk

Jennifer Fulk holds the CFO seat at Kura Oncology, Inc. on the record, Chief Financial Officer, principal financial officer, effective September 8, 2026.

1 verified record · 1 company · current seat on the record: Kura Oncology, Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-09-08TransitionKura Oncology, Inc.current seat

    Kura Oncology, Inc. CFO transition: Jennifer Fulk to succeed Troy E. Wilson, Ph.D., J.D.

    Named as the incoming officer, Chief Financial Officer, principal financial officer

    effective September 8, 2026 · 8-K filed September 8, 2026 · sec.gov, Item 5.02

Companies

1

Kura Oncology, Inc.KURA

Pharmaceutical Preparations

This page lists only verified filing records that name Jennifer Fulk, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.